ARTHEX BIOTECH S.L.
EIC Accelerator Winner From 2022
First In class oliGo THerapy for Myotonic Dystrophy type 1 (DM1)
Spain
Articles
EIC Accelerator Funding Boosts ARTHEX BIOTECH's Innovative DM1 Treatment Development
SpainEIC Accelerator2022
Read Article